| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Chief Commercial Officer | Common Stock | 72,868 | $928,338 | $12.74 | 23 Dec 2025 | Direct |
| OptimizeRx Corp | Chief Commercial Officer | Stock Option | 35,156 | 21 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OPRX | OptimizeRx Corp | 23 Dec 2025 | 1 | -$18,091 | 4 | Chief Commercial Officer | 23 Dec 2025, 16:55 |
| OPRX | OptimizeRx Corp | 01 Nov 2025 | 1 | -$34,690 | 4 | Chief Commercial Officer | 03 Nov 2025, 20:12 |
| OPRX | OptimizeRx Corp | 21 Aug 2025 | 2 | $0 | 4 | Chief Commercial Officer | 25 Aug 2025, 15:17 |
| OPRX | OptimizeRx Corp | 15 May 2025 | 3 | $0 | 4 | Chief Commercial Officer | 19 May 2025, 16:04 |
| OPRX | OptimizeRx Corp | 23 Dec 2024 | 2 | $0 | 4 | Chief Commercial Officer | 27 Dec 2024, 14:09 |
| OPRX | OptimizeRx Corp | 01 Nov 2024 | 1 | -$8,719 | 4 | Chief Commercial Officer | 05 Nov 2024, 20:30 |
| OPRX | OptimizeRx Corp | 01 Nov 2023 | 2 | $0 | 4 | Chief Commercial Officer | 03 Nov 2023, 10:49 |
| OPRX | OptimizeRx Corp | 24 Oct 2023 | 0 | $0 | 3 | Chief Commercial Officer | 30 Oct 2023, 16:06 |